1-800-567-8911 or
604-682-5050
(Telephone interpreting in over 150 languages available)
Vemurafenib
Trade Name:
Zelboraf
Manufacturer/Distributor:
Hoffman-La Roche
www.rochecanada.com 1-800-561-1759
Classification:
Antineoplastic agent
ATC Class:
L01XE15 - vemurafenib
Status:
active
Notice of Compliance (yyyy/mm/dd):
2012/02/15
Date Marketed in Canada (yyyy/mm/dd):
2012/02
Presentation:
Tablet: 240 mg. DIN: 02380242
Comments:
Vemurafenib is indicated as monotherapy for the treatment of BRAF V600 mutation-positive unresectable or metastatic melanoma. A validated test is required to identify BRAF V600 mutation status.
Back to:
Drug Product Listings 
